retatrutide biolongevity labs GLP-3 (11378) GLP-3 (251531E) - BioLongevity Labs

#Biosimilars #FDA #Healthcare To view or add a comment, sign in FDA Update for Prescribers A new drug safety communication urges healthcare professionals to prioritize individualized, informed, shared decision-making between patient and physician when prescribing opioids

This slow-release mechanism not only prolongs the duration of action of GHK-Cu but also ensures its sustained action in small doses, which is in line with the prerequisites for wound healing

10.1038/nrm1261 Nat

A steady dose

The Mayo Clinic shares that those most at risk of low levels include (5): people who dont consume enough vitamin B12 in their diet people diagnosed with pernicious anemia people whove had gastric surgeries people with intestinal issues, such as celiac or Crohns disease People following a vegetarian diet are especially at risk of deficiency